Regeneron Pharma (REGN) PT Raised to $916 at Bernstein
Tweet Send to a Friend
Bernstein SocGen Group analyst William Pickering raised the price target on Regeneron Pharma (NASDAQ: REGN) to $916.00 (from $911.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
